CHIMERIX INC. - COMMO
0.9351
07-نوفمبر-24 15:59:42
15 متأخرة بدقائق
الأسهم
-0.0749
-7.42%
نطاق اليوم
0.9079 - 1.0500
ISIN
N/A
المصدر
NASDAQ
-
Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference
28 فبراير 2023 16:05:01 بحسب Nasdaq GlobeNewswire
-
23 فبراير 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference
05 يناير 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
08 ديسمبر 2022 17:00:00 بحسب Nasdaq GlobeNewswire
-
Chimerix Responds to Rubric Capital Management
10 نوفمبر 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update
03 نوفمبر 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
27 أكتوبر 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions
26 سبتمبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference
06 سبتمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
29 أغسطس 2022 10:45:00 بحسب Nasdaq GlobeNewswire
-
Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update
08 أغسطس 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs
08 أغسطس 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Chimerix to Present at Wedbush PacGrow Healthcare Conference
02 أغسطس 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
01 أغسطس 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
24 يونيو 2022 10:06:16 بحسب Nasdaq GlobeNewswire
-
Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement
23 يونيو 2022 09:15:16 بحسب Nasdaq GlobeNewswire
-
Chimerix to Present at Jefferies Global Healthcare Conference
01 يونيو 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
Chimerix to Present at H.C. Wainwright Global Investment Conference
17 مايو 2022 16:15:00 بحسب Nasdaq GlobeNewswire
-
Chimerix Reports First Quarter 2022 Financial Results and Provides Operational Update
16 مايو 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties
16 مايو 2022 06:30:00 بحسب Nasdaq GlobeNewswire